CD276 and neoplasm: Tumors treated with 3E8 mAb were up to three times smaller than those treated with the IgG control at the experimental end point (4 weeks, Figure 5G), the effects of which were not obvious on tumor cells knocked down for B7‐H3 expression (Figure 5H).